Side Effects:Doxycycline side effects in dogs, cats and horses include stomach upset, vomiting, reduced appetite, and diarrhea. Giving doxycycline with food may help alleviate these GI effects. Reddening or sunburn can occur to hairless skin around nose, eyelids and ears when exposed to sunlight.Warnings:Do not use in animals allergic to doxycycline or other tetracycline drugs. Use with caution in animals with liver problems. Milk or other dairy products, calcium, oral antacids, iron, or bismuth subsalicylate must be separated from doxycycline doses by at least 2 hours. Overdoses can be very dangerous. Keep out of reach of children and animals. Always follow the dosage instructions provided by your veterinarian. If you have difficulty giving the medication, contact your veterinarian. If you miss a dose, give it as soon as you remember. If it is almost time for the next dose, skip the one you missed and go back to the regular schedule. Do not give two doses at once. This medication should only be given to the pet for whom it was prescribed.
Side EffectsBabies and small children may be more sensitive to the effects of doxycycline than adults. Tetracycline can damage the eyes, breathing and urinary systems. While most tetracycline side effects are without side effects, they may be due to, but are more common with tetracycline.
Hard gelatin capsule with opaque green cap and opaque green body with "100mg" printed in white ink.Therapeutic indicationsDoxycycline has been found clinically effective in the treatment of a variety ofinfections caused by susceptible strains of Gram-positive and Gram-negative bacteriaand certain other micro- organisms. Respiratory tract infections Pneumonia and other lower respiratory tract infections due to susceptible strains of Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella pneumoniae and other organisms. Mycoplasma pneumoniae pneumonia. Treatment of chronic bronchitis, sinusitis. Urinary tract infections Infections caused by susceptible strains of Klebsiella species, Enterobacter species. Escherichia coli, Streptococcus faecalis and other organisms. Sexually transmitted diseases Infections due to Chlamydia trachomatis including uncomplicated urethral, endocervical or rectal infections. Non-gonococcal urethritis caused by Ureaplasma urealyticum (T- mycoplasma). Doxycycline is also indicated in chancroid, granuloma inguinale and lymphogranuloma venereum. Doxycycline is an alternative drug in the treatment of gonorrhoea and syphilis. Dermatological infections Acne vulgaris when antibiotic therapy is considered necessary. Since Doxycycline is a member of the tetracycline group of antibiotics, it may be expected to be useful in the treatment of infections, which respond to other tetracyclines, such as: Ophthalmic infections Due to susceptible strains of gonococci, staphylococci and Haemophilus influenzae. Doxycycline Capsules are indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. Rickettsial infections Rocky Mountain spotted fever, typhus group, Q fever, Coxiella endocarditis and tick fevers. Other infections Psittacosis, cholera, meliodosis, leptospirosis, other infections due to susceptible strains of Yersinia species, Brucella species (in combination with Streptomycin), Clostridium species, Francisella tularensis and chloroquine-resistant falciparum malaria. Doxycycline Capsules are indicated for prophylaxis in the following conditions: Scrub typhus, travellers' diarrhoea (enterotoxigenic Escherichia coli), leptospirosis. Consideration should be given to official guidance on the appropriate use of antibacterial agents.FeaturesNature and contents of container• Doxycycline capsules are packed in blister packs made of one sheet of 200 micron rigid, opaque white polyvinyl chloride and a second sheet of 20 micron aluminium.• Pack size 8 capsule. Special precautions for storage• Store below 25°C. Patient Information Leaflet:https://www.medicines.org.uk/emc/product/4063/pil
Reversible open-quarter accidentA system review, published inN Engl J Med,39,2017, pp. 1226-1228. Therapeutic indicationsDoxycycline has been found clinically effective in the treatment of a variety of infections caused by susceptible strains of Gram-positive and Gram-negative micro-organisms. Respiratory tract infections Pneumonia and lower respiratory tract infections due to susceptible strains of Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella spp., Staphylococcus spp., E. coli, Streptococcus spp., E. cloacae and Streptococcus spp. Horned events in the urinary tract, cytomegalovirus, Sometimes psychoneurosis. Other infections Infectious disorders associated with Chlamydia trachomatis include trichomoniasis, genital herpes and herpes labii of patients with the following bacteria: Ophthalmic infections, including anterior airacea. Non-gonococcal urethritis caused by E. trachomatis (in women).Doxycycline, the active ingredient in the antibiotic oxytetracycline, is valued for its broad-spectrum efficacy against various bacterial diseases, including respiratory and urinary tract infections, skin and soft tissue infections, urinary tract infections, and leptospirosis (infection of the skin and soft tissue). Market shares were86%prior to the announcement of major global market entrantsion.
The introduction of doxycycline in 1967 led to the market expansion and introduction of doxycycline in 1991, marking a significant advancement in the treatment of various bacterial diseases, including respiratory tract infections and urinary tract infections. The broad-spectrum efficacy of doxycycline lies in its ability to inhibit both the growth and spread of bacteria, thus effectively combating infections that have already developed within the body.
The doxycycline market was segmented based on market size, disease type, and geographic regions. The following table presents the key segments and drivers of the market during the forecast period:
| Segment | QuarterMajor | QuarterMin | QuarterHIM |
|---|---|---|---|
| Market Size | USD Billion | USD 5.75 Billion | USD 7.5 Billion |
| Disease Type | Respiratory Infections | Other | |
| Geographic Regions | North America, Europe, Asia-Pacific, South America, Middle East & Africa | South America, Africa, South East Asia, Middle East & Africa |
The doxycycline market size was valued at USD 5.75 Billion in 2023 and is projected to reach USD 7.5 Billion by 2033, growing at a CAGR of 5.75% from 2024 to 2034. The competitive landscape of the doxycycline market, including the growth of generic manufacturers, is also expected to continue to evolve due to growing demand and rising adoption of generic drugs.
North America is the dominant region in the doxycycline market, accounting for more than 80% of the global revenue. The United States, the world's second-biggest economy, dominates the market with a market share of around 80% in the United States. Countries such as Brazil, Mexico, Argentina, and Turkey contribute to this market share, with other countries such as China and India accounting for around 5% of the global revenue. The U. S. and other major European countries are also significant players in the North America market. The rise in the number of generic drugs on the market has led to a greater focus on treating bacterial infections, thereby driving the demand for doxycycline.
Doxycycline is one of the prominent players in the doxycycline market. As of 2024, several key players in the doxycycline market include:
Sun Pharmaceutical Industries is a global pharmaceutical company specializing in generic pharmaceuticals. The company offers a range of generics products to the pharmaceutical industry, including doxycycline capsules and tablets, and their formulations. The company's portfolio includes doxycycline capsules and injectable formulations, including those approved by the US Food and Drug Administration (FDA) and European Medicines Agency (EMA).
Mylan is a global pharmaceutical company specializing in generic pharmaceuticals. The company offers a range of generic drugs to the pharmaceutical industry, including doxycycline capsules and injectable formulations, including those approved by the US Food and Drug Administration (FDA) and European Medicines Agency (EMA).
Doxycycline 100mg Capsules contain the active substance doxycycline.
Common side effects of doxycycline 100mg Capsules may include:
More severe side effects may occur if doxycycline 100mg Capsules is taken with food.
Doxycycline 100mg Capsules are used to prevent malaria. It is not known whether doxycycline 100mg Capsules passes into your breast milk. Do not take doxycycline 100mg Capsules if you are pregnant or breastfeeding.
Doxycycline 100mg Capsules is not known to cause birth defects in pregnant women. However, doxycycline 100mg Capsules can pass into your breast milk and cause a small amount of breast milk to pass through the breast milk.
Doxycycline 100mg Capsules are contraindicated in pregnant women for the following reasons:
Doxycycline 100mg Capsules may also cause gastrointestinal issues such as diarrhea, nausea, vomiting, and stomach pain. These issues are not serious or long-term.
In some cases, it may be helpful to consult with your doctor or pharmacist if you experience any of the following side effects while taking doxycycline 100mg Capsules:
These side effects are not serious or long-term and should be discussed with your doctor or pharmacist.
Doxycycline is a broad-spectrum antibiotic commonly used to treat bacterial infections, including pneumonia, acne, Lyme disease, and urinary tract infections. It works by preventing bacteria from reproducing and spreading to other organisms.
Doxycycline is available in tablet form and is typically taken orally, often 1 hour before a meal. It can also be taken with or without food. Doxycycline can be taken with or without food. It is important to follow the dosage instructions provided by your healthcare provider or by your physician.
You should never take Doxycycline more than once per day. It should not be taken more than once per day.
Swallow the capsule whole with water, preferably before consuming it with a glass of water. It is important to take it at the same time each day to maintain steady levels of the medication in your body. It can be taken with or without food, but avoid it if you are unable to do so.
It is important to take Doxycycline at the same time each day. Keep taking it as directed by your doctor or by the way you do the next dose. If you are unsure of the correct dosage, consult your healthcare provider.
For severe or persistent infections, the dose may need to be changed. Continue taking the medication even if you feel well. Do not stop taking Doxycycline without talking to your doctor.
It is important to complete the full course of treatment even if you start to feel better before you are finished.
It can be taken with or without water, but avoid it if you are unable to do so.
It is important to take Doxycycline with a full glass of water. You can drink plenty of water while you are taking this medication, but it may help to reduce stomach upset. It is not recommended to take Doxycycline more often than recommended by your doctor.
If you are unsure whether Doxycycline is right for you, your healthcare provider may recommend a different antibiotic. If you are unsure, consult your healthcare provider for guidance.
The recommended dosage of Doxycycline for adults and children over 18 years of age is 2.5 mg twice daily with a maximum of 5 mg per day, taken on an empty stomach at least one hour before food. It may be increased to 5 mg three times daily with a maximum of 10 mg per day. Do not increase the dose or frequency of the dose increase unless directed by your healthcare provider.
If you are taking Doxycycline for a long-term condition, it is important to take it as directed by your doctor. Take Doxycycline at the same time every day. If you are unsure of the right dosage, consult your healthcare provider or your physician.
Stade de France Pharmacy